by symptomatic congenital heart defects may remain long undetected and be discovered incidentally only during cardiological, anaesthetic, or diagnostic procedures [3, 12, 13, 18, 22, 23] . One of such venous variations is the presence of persistent left superior caval vein (PLSCV) (Fig. 1) .
The most common approach in CIED, pacemaker (PM), and implantable cardioverter-defibrillator (ICD) implantation procedures is the use of venous vessels for cardiac lead insertion. Successful transvenous lead advancement is determined by favourable anatomical arrangement of venous structures along the course from the site of lead insertion to its final placement [5, 7] .
In this study, the developmental venous anomaly (i.e. PLSCV) was detected as a result of visualising the contrast-enhanced venous lumen during CIED implantation. The fact that these anomalies were undetected prior to the procedure due to their asymptomatic nature resulted in venography being the only diagnostic assessment available intraprocedurally. The selection of the optimal approach and the route of cardiac lead insertion were made possible by visualising anatomical and morphometric parameters of the altered venous system [4] .
The aim of this paper was to illustrate PLSCV variations encountered during CIED implantation procedures.
MAtErIALS And MEtHodS
We analysed 5,010 CIED implantation procedures with transvenous lead insertion performed at our centre in the years 2003-2015, including de-novo PM and ICD implantations. During the analysed period, 10 cases of PLSCV-type systemic vein anomalies were detected ( Table 1) .
The CIEDs were implanted in the left infraclavicular region and the cardiac leads were inserted using cephalic vein (CV) cut-down and/or axillary vein (AV) or subclavian vein (SV) puncture.
In order to visualise the cause of problems emerging during cardiac lead advancement and/or in situations where the vessel had an atypical course, a contrast agent was administered into the ipsilateral CV or AV/SV. Contrast flow in the veins was recorded in an anteriorposterior view via C-arm angiocardiography. Films were taken at 8 Fr/s with individual frame documentation (some images were used as figures presented in this article). Contrast flow in the evaluated vessels was visualised following administration of 15-30 mL (mean 20 mL) of a contrast agent, depending on interindividual variations in venous bed volume in the evaluated area.
After the procedure, in order to more specifically determine the intraprocedurally detected anomaly, a computed tomography (CT) scan and/or a 2-dimensional/3-dimensional (2D/3D) ultrasound examination was performed in some cases, depending on indications.
Our statistical analysis used numerical variables in the form of mean values.
rESuLtS
A total of 5,010 de-novo CIED implantation procedures with transvenous cardiac lead placement were performed in the analysed period of time. The study group comprised 52% of females and 48% of males. Venous access via the left infraclavicular region was used in 97% of patients. Persistent left superior caval vein were detected in 10 patients (mean age 66 ± 14 years), including 9 cases during PM implantation and 1 case during ICD implantation. This venous anomaly was detected in 5 females (mean age 73 ± 15 years) and 5 males (mean age 60 ± 10 years), who constituted 0.2% of the analysed population. Three morphoanatomical variations of this venous anomaly were detected and the recorded visual evidence of the most representative cases was presented in this article.
In all 10 cases, the PLSCVs drained into the right atrium (RA) via the coronary sinus (CS).
Three patients (mean age 65 ± 25 years) were shown to have double superior vena cava (DSVC) with a brachiocephalic vein (BCV) bridge. This anatomical variation was illustrated with the venography image obtained during a CIED implantation procedure (Fig. 2) .
The venous anomaly cases were characterised by a relatively low left BCV diameter, which is likely due to the coexistence of two venous drainage routes via the right superior vena cava (RSVC) and left superior vena cava (LSVC), sharing between them venous drainage of the thorax. Three patients (mean age 73 ± 10 years) had DSVC without BCV bridging. This venous variation was illustrated via intraprocedural bilateral venography (Fig. 3) .
Four patients (mean age 62 ± 9 years) developed a form of a single PLSVC with concomitant RSVC agenesis. An intraprocedural contrast venography of the right forearm showed smooth contrast flow through the BCV into the LSVC and, subsequently, through the CS into the RA (Fig. 4) .
Transthoracic echocardiography (TTE) conducted after the procedure showed no evidence of a coexisting congenital heart defect in any of the patients. 3D TTE showed the special position of cardiac leads and heart chambers (assessment conducted after the procedure) (Fig. 5) .
Computed tomography scans showed the PLSCVs presented in this article to have similar topography, which was illustrated in Figure 6 . The LSVC courses vertically from the point of confluence of the left jugular vein and left SV, located posterior to the articulation of the first rib and the sternum (Th2/Th3 level). In its initial segment the PLSVC lies anterior and lateral to the aortic arch, at the level of Th6 the vessel is adjacent anteriorly to the left pulmonary vein, and below -to the left main bronchus, finally draining into the CS at the level of Th8/Th9 (Figs. 7, 8 ). The diameter of these vessels in the evaluated cases ranged from 2 × 25 mm to 18 mm and depended on the level at which the vessel was measured.
Known dimensions of cardiac lead components (e.g. Medtronic screw-in leads with a deployed lead tip measuring 18 mm, Fig. 3C ), helped indirectly estimate the vascular diameter already during the procedure.
dIScuSSIon
The lack of symptoms in the case of vascular anomalies is the reason why they can be detected only in favourable circumstances, an example of which is PLSCV [7, 11, 19, 23] . The PLSCV, found in approximately 0.3-0.5% of the population, is usually detected on echocardiography, CT, postmortem, or invasive cardiac procedures, such as transvenous CIED implantation [12, 13, 15, 22] . The population analysed in our centre exhibited a 0.2% prevalence of this venous anomaly.
During normal embryonic development, the initially symmetrical venous system is composed of two pairs of cardinal veins (anterior and posterior), collecting blood from the cephalic and caudal regions of the embryo, respectively. These pairs of veins anas- tomose to form the right and left common cardinal veins (ducts of Cuvier). The left common cardinal vein forms the CS and oblique veins of the left atrium (LA). In gestational week 8, the BCV forms as a result of anastomosis of both, right and left, superior cardinal veins. In its mature form, the final segment of the right anterior cardinal vein forms the RSVC. By gestational week 20, in normally developing embryo the left tube atrophies and blood flow is redistributed to the right side. The anatomical remnants are Marshall's ligament and vein coursing over the LA and marking the anatomical beginning of the CS, which ends in the RA [1, 2, 21] . The presence of PLSCV is a consequence of a lack of normal atrophy of the left anterior cardinal vein in the embryonic life. An effect of a patent PLSCV in adult life is drainage of venous blood into the CS or directly into the RA, rarely into the LA (90% and 10% of cases, respectively) [3] . In the absence of coexisting congenital defects, the presence of PLSCV draining into the RA is typically asymptomatic.
A PLSCV draining into the LA with a left-to-right shunt is observed sporadically. Such a configuration is usually associated with symptomatic cardiovascular pathologies (unroofed coronary sinus defect type I) [7, 9, 24, 27, 28] .
The PLSCV more commonly coexists with congenital heart defects (3-10%), with the literature reporting various rates of PLSCV prevalence in children and adults, as well as for different diagnostic techniques [6, 13, 18, 20] .
The PLSCVs detected in our patient group over the analysed period of time can be classified into three distinct variations: two variations of DSVC (one with and the other without BCV bridging) and a single PLSVC with RSVC agenesis [3, 10, 25, 26] . In 6 out of 10 (60%) cases of PLSCVs the vessel was found to coexist with the RSVC.
Failure of a bridge to form between both anterior cardinal veins leads to a lack of BCV connecting the DSVC. This vascular configuration was found in 3 out of 6 (50%) of the analysed patients [18, 22] . A DSVC with a BCV bridge was also found in 3 cases; however, this vascular configuration may be somewhat more common, due to the fact that cases where the angle formed by the BCV bridge facilitates direct lead advancement to the RSVC may remain undetected.
Developmental malformations of the right cardinal vein leading to RSVC agenesis were observed in 4 in 10 (40%) evaluated patients. This variation is noteworthy because venous drainage from the upper part of the body into the RA takes place solely via the PLSCV, posing a haemodynamic burden on the CS [18, 22, 23] .
Transthoracic echocardiography assessments performed in the evaluated patients revealed no congenital heart defects. Despite technical advancement of the imaging equipment and quality, the use of this method in our study was limited to obtaining data on CS size (potential effects of increased venous flow) and locating lead position. CT scans confirming the initial venography-based diagnosis were the only method of obtaining more precise data on PLSCV location in relation to thoracic structures and organs [14, 17] .
Literature reports typically present isolated cases of a specific PLSCV variation [4, 11, 16, 19, 25] . This article presents PLSCV topography and morphometry in 10 cases of this venous malformation diagnosed during CIED implantation procedures, based on various techniques used to visualize each of the three representative variations.
Limitations of the study
All CIED implantation procedures at our centre are conducted on the left side of the body, which could affect the estimated prevalence of this venous anomaly in the analysed population with respect to its actual prevalence in the general population.
The clinical as well as outpatient follow-up aspects of our study were limited in favour of presenting various imaging methods used to visualise PLSCV morphometry and topography.
concLuSIonS
The PLSCV-type venous anomaly was detected in 0.2% of the analysed patients undergoing de-novo CIED implantation procedures.
The three distinct anatomic PLSCV variations showed interindividual morphometric differences.
rEfErEncES
